• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对五个高分子量激肽原缺乏症日本家族的分子遗传学调查。

Molecular genetic survey of five Japanese families with high-molecular-weight kininogen deficiency.

作者信息

Hayashi H, Ishimaru F, Fujita T, Tsurumi N, Tsuda T, Kimura I

机构信息

Departments of Blood Transfusion and Internal Medicine, Okayama University Medical School, Japan.

出版信息

Blood. 1990 Mar 15;75(6):1296-304.

PMID:1968772
Abstract

Analyses of the kininogen (KGN) molecule and KGN gene status in five Japanese families with high-molecular-weight (HMW) KGN deficiency were performed by the immunoblotting method with monoclonal antibodies to HMW-KGN, and by the Southern blotting method with the cDNA for human low-molecular-weight prekininogen. No molecular abnormality of KGN was detected in the DNA from four patients with total KGN deficiency or one patient with isolated HMW-KGN deficiency. In the former, the KGN gene appeared to be grossly normal at the level of the whole genome on Southern blotting. In isolated HMW-KGN deficiency, a partial deletion in intron 7 was found by restriction analyses of EcoRI, BamHI, HindIII, Sca I, and Bgl II fragments. This partial deletion is assumed to be related to an abnormality of the alternative RNA splicing events for HMW-prekininogen mRNA.

摘要

采用针对高分子量激肽原(HMW-KGN)的单克隆抗体免疫印迹法,以及用人低分子量前激肽原cDNA进行的Southern印迹法,对五个患有高分子量激肽原(HMW-KGN)缺乏症的日本家庭中的激肽原(KGN)分子和KGN基因状态进行了分析。在四名全KGN缺乏症患者或一名孤立性HMW-KGN缺乏症患者的DNA中未检测到KGN的分子异常。在前者中,Southern印迹显示KGN基因在整个基因组水平上大致正常。在孤立性HMW-KGN缺乏症中,通过对EcoRI、BamHI、HindIII、Sca I和Bgl II片段的限制性分析,发现内含子7存在部分缺失。这种部分缺失被认为与HMW-前激肽原mRNA的可变RNA剪接事件异常有关。

相似文献

1
Molecular genetic survey of five Japanese families with high-molecular-weight kininogen deficiency.对五个高分子量激肽原缺乏症日本家族的分子遗传学调查。
Blood. 1990 Mar 15;75(6):1296-304.
2
[DNA analysis for the kininogen gene of patients with kininogen deficiency in Japan].
Rinsho Ketsueki. 1989 Oct;30(10):1694-701.
3
Molecular characterization of total kininogen deficiency in Japanese patients.
Int J Hematol. 1999 Feb;69(2):126-8.
4
The high-molecular-mass kininogen deficient rat expresses all kininogen mRNA species, but does not export the high-molecular-mass kininogen synthesized.
FEBS Lett. 1988 Oct 24;239(1):59-64. doi: 10.1016/0014-5793(88)80545-3.
5
Mapping of functional domains of human high molecular weight and low molecular weight kininogens using murine monoclonal antibodies.利用鼠单克隆抗体对人高分子量和低分子量激肽原的功能结构域进行定位。
Biochemistry. 1987 Nov 3;26(22):7021-9. doi: 10.1021/bi00396a025.
6
A single gene for bovine high molecular weight and low molecular weight kininogens.
Nature. 1983;305(5934):545-9. doi: 10.1038/305545a0.
7
Structural organization of the human kininogen gene and a model for its evolution.
J Biol Chem. 1985 Jul 15;260(14):8610-7.
8
Molecular cloning of cDNAs for mouse low-molecular-weight and high-molecular-weight prekininogens.
Biochim Biophys Acta. 1997 May 30;1352(2):222-30. doi: 10.1016/s0167-4781(97)00018-3.
9
Kininogen deficiency in the rat.大鼠激肽原缺乏症。
Agents Actions Suppl. 1992;38 ( Pt 1):277-91. doi: 10.1007/978-3-0348-7321-5_36.
10
Characterization of the heredity of kininogen deficiency in brown Norway Katholiek strain rats.棕色挪威天主教品系大鼠激肽原缺乏症的遗传特征分析。
Life Sci. 1992;51(2):135-42. doi: 10.1016/0024-3205(92)90007-c.

引用本文的文献

1
Human plasma kallikrein-kinin system: physiological and biochemical parameters.人血浆激肽释放酶-激肽系统:生理和生化参数
Cardiovasc Hematol Agents Med Chem. 2009 Jul;7(3):234-50. doi: 10.2174/187152509789105444.
2
Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis.删除小鼠激肽原基因1(mKng1)会导致血浆激肽原缺失并延迟血栓形成。
Blood. 2008 Feb 1;111(3):1274-81. doi: 10.1182/blood-2007-06-092338. Epub 2007 Nov 13.